Antioxidants
| Zeile 21: | Zeile 21: | ||
{{tp|p=32345063|t=2020. Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic |pdf=|usr=}} | {{tp|p=32345063|t=2020. Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic |pdf=|usr=}} | ||
{{tp|p=32503814|t=2020. COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.|pdf=|usr=007}} | {{tp|p=32503814|t=2020. COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.|pdf=|usr=007}} | ||
| + | {{tp|p=32504923|t=2020. N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2.|pdf=|usr=009}} | ||
| + | |||
| + | '''DMSO''' | ||
| + | {{tp|p=32473509|t=2020. Zinc Iodide in combination with Dimethyl Sulfoxide for treatment of SARS-CoV-2 and other viral infections.|pdf=|usr=009}} | ||
| + | |||
'''Heme oxygenase''' as taregt | '''Heme oxygenase''' as taregt | ||
{{tp|p=32500379|t=2020. COVID-19 and heme oxygenase: novel insight into the disease and potential therapies.|pdf=|usr=008}} | {{tp|p=32500379|t=2020. COVID-19 and heme oxygenase: novel insight into the disease and potential therapies.|pdf=|usr=008}} | ||
| + | |||
| + | '''HIF1''' | ||
| + | {{tp|p=32464493|t=2020. Hypoxia inducible factor-1 protects against COVID-19: A hypothesis.|pdf=|usr=009}} | ||
'''mix''' | '''mix''' | ||
{{tp|p=32321655|t=ä. An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients |pdf=|usr=}} | {{tp|p=32321655|t=ä. An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients |pdf=|usr=}} | ||
Version vom 7. Juli 2020, 15:24 Uhr
32521619 2020. Redox-Modulating Agents in the Treatment of Viral Infections.
Glutathione GSH antioxidant
| 32322478 2020. Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases |
32454047 2020. An evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19.
Vitamin C
32264963 2020. A new clinical trial to test high-dose vitamin C in patients with COVID-19
32328576 2020. Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?
32322486 2020. Intravenous vitamin C for reduction of cytokines storm in acute respiratory distress syndrome
C7203037 ä. (Vitamin-C; Ozone)Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19?
32471171 2020. Excess Ascorbate is a Chemical Stress Agent against Proteins and Cells.
32468742 2020. Reply: Vitamin C as a Possible Therapy for COVID-19.
32410417 2020. Vitamin C as a Possible Therapy for COVID-19.
NAC
32344315 2020. N-acetyl-cysteine may prevent COVID-19-associated cytokine storm and acute respiratory distress syndrome
32345063 2020. Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic
32503814 2020. COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.
32504923 2020. N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2.
DMSO
32473509 2020. Zinc Iodide in combination with Dimethyl Sulfoxide for treatment of SARS-CoV-2 and other viral infections.
Heme oxygenase as taregt
32500379 2020. COVID-19 and heme oxygenase: novel insight into the disease and potential therapies.
HIF1
32464493 2020. Hypoxia inducible factor-1 protects against COVID-19: A hypothesis.
mix
32321655 ä. An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients
